40 likes | 150 Views
Supplemental Table S1. Complete list of LC-MS myc interating protiens in the MCF7 cells, proteins highlighted in red are those differentially expressed from the LCC1 and LCC1 EGF treated cells. Supplemental Table S2.
E N D
Supplemental Table S1 Complete list of LC-MS myc interating protiens in the MCF7 cells, proteins highlighted in red are those differentially expressed from the LCC1 and LCC1 EGF treated cells.
Supplemental Table S2 Complete list of LC-MS myc interating protiens in the LCC1 cells, proteins highlighted in red are those differentially expressed from the LCC1 EGF and MCF7 cells
Supplemental Table S3 Complete list of LC-MS myc interating protiens in the LCC1 EGF treated cells, proteins highlighted in red are those differentially expressed from the LCC1 and MCF7 cells
Supplemental Table S4 Clinical trials examining the potential benefit of trastuzumab in Her2 low/Her2 negative breast cancer patients